跳至主要内容
临床试验/CTIS2023-506162-31-00
CTIS2023-506162-31-00进行中(未招募)1 期

A randomized controlled trial comparing sequential of two shots of CFA vs CFA + rFSH for Elective Fertility Preservation. The 2-shot protocol. - FSD-SEQ-2023-09

Santiago Dexeus Font Fundacio Privada0 个研究点目标入组 194 人开始时间: 2023年8月30日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
194

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 64(—)

入选标准

  • AFC = 20, Anti-Mullerian hormone (AMH) = 3ng/ml (AMH result of up to one year will be valid), Between 18 and 40 years old, BMI > 18 and < 30 kg/m2, Able to come to the Center to comply with the procedures of the study: blood tests, appointments and drug dispensation

排除标准

  • Medically indicated fertility preservation, AFC > 20, Polycystic ovarian syndrome (PCOS) according to the Rotterdam criteria, FSH = 20, History of untreated autoimmune, endocrine, or metabolic disorders, Contraindication for hormonal treatment, Recent history of severe disease requiring regular treatment (clinically significant concurrent medical condition that could compromise subject safety or interfered with the trial assessment).

研究者

发起方
Santiago Dexeus Font Fundacio Privada

相似试验